Kerala High Court Hears Plea on ‘Exorbitant’ Pricing of Ribociclib
The Kerala High Court permitted a breast cancer patient to be impleaded in a petition examining the “exorbitant” price of Ribociclib, described as a life-saving breast cancer medicine. Ribociclib is a CDK 4/6 (cyclin-dependent kinase) inhibitor used with other medicines and always alongside hormone therapy for certain advanced, metastatic, or locally advanced breast cancers; it blocks kinase to inhibit cancer growth and spread, with possible serious adverse effects.
The Hindu


